Prognosis of colorectal cancer

The prognosis for bowel cancer is better the earlier the disease is detected and treated. 90% of patients are alive after five years if the cancer is detected when it is limited to the bowel wall. In addition to the spread of the tumor, the prognosis is affected by the patient’s age, general condition, complications caused by the tumor, and the degree of differentiation of the tumor.

In short

  • The prognosis for bowel cancer is better if the disease is detected and treated early.
  • Approximately 90% of patients are alive after five years if the cancer is confined to the bowel wall at the time of diagnosis.
  • The prognosis is affected by the extent of the tumour, as well as the patient’s age, general condition and tumour characteristics.
  • Improvements in surgical techniques and new drug treatments have significantly improved treatment outcomes.
  • The cancer usually recurs within 2–3 years of surgery, and recurrences after five years are rare.

Prognosis

Finland ranks among the top Western European countries regarding colorectal cancer treatment outcomes. Advances in surgical techniques, along with new chemotherapies and targeted medical treatments, have significantly improved these outcomes. Following surgery and any potential adjuvant therapies, the primary goal is to minimize the risk of local recurrence or metastasis.

If colorectal cancer does recur, it is most likely to do so within 2 to 3 years after surgery. Recurrences are rare after five years, which is why the follow-up monitoring for colorectal cancer patients is typically concluded after five years.